title: Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: R
authors.initials: R
authors.lastname: Duquesnoy
authors.forename: Y
authors.initials: Y
authors.lastname: Iwaki
authors.forename: J
authors.initials: J
authors.lastname: Demetris
authors.forename: A
authors.initials: A
authors.lastname: Yagihashi
authors.forename: O
authors.initials: O
authors.lastname: Bronsther
authors.forename: S
authors.initials: S
authors.lastname: Iwatsuki
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D016559:Tacrolimus; D014184:Transplantation, Homologous
chemical_list: D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016559:Tacrolimus